Why Attend
The Onco Cell Therapy Summit is returning face-to-face in Amsterdam as the hub of the European cell therapy industry.
Realise the full potential of your cell therapy biotechnology. Join talks exploring novel target discovery platforms, engineering cells to overcome the tumour microenvironment, automating manufacturing & analytics and next-generation pre-clinical models.
Europe is a powerhouse of research, but has been struggling to keep pace with development in the US. Get multiple perspectives in panels how to attract investment from C-suite executives and investors themselves, and explore European regulatory and reimbursement challenges for the cell therapy field.
Make the most of the end of restrictions, and catch up with peers and form new connections in our 5+ hours of networking time to share details and explore partnership opportunities, all made effortless through our networking app.
Mission Statement
With J&J’s landmark BCMA CAR-T approval marking the 6th approved CAR-T therapy, the cancer cell therapy field has definitively progressed beyond its nascent stage. Europe is a hub of research activity in the CGT space, and is home to industry-leading biotechs developing cell therapies that are more advanced, efficacious and accessible.
Despite this, Europe faces significant challenges with investment, regulation and staffing, alongside the wider R&D challenges in the field of developing more affordable therapies, treatments for solid tumors, and off-the-shelf allogeneic products.
The Onco Cell Therapy Summit Europe is the only event on mainland Europe bringing together industry experts in cancer cell therapy. The conference covers the full range of autologous and allogeneic modalities, and will explore in-depth the challenges across R&D, manufacturing, logistics, regulation and investment.
LEADING INDUSTRY MINDS FROM OUR PREVIOUS EVENT
Adrian Bot
Dr. Christina Coughlin
Michael Hudecek
Jason Litten
Dan Kaufman
Alice Brown
John Rossi
Blake Aftab
Tony Ho
Steven Kanner
Dr John Maher
Professor Ann Ager
Dr Detlev Parow
Evren Alici
Prof. Torsten Tonn
Deepak Raj
Nick Huntington
James Patterson
Frank Thielmann
Eytan Breman
Hanspeter Gerber
Volker Huppert
Robert Kochl
Darrell Irvine
Professor Graham Pockley
Stephen Feldman
Reagan Jarvis
Paul Rennert
Dan Shelly
Kenneth Warrington
Ken Warrington, PhD joined GenScript Probio in 2020 as Head of Strategy & Innovation and a Sr. Director of Business Development supporting their Gene & Cell Therapy CMC services. Dr. Warrington served on the faculty at the University of Florida focused on AAV vector development and transitioned into industry where he has served lead technical operation and business development roles for global contract testing and manufacturing organizations. He is a co-founder and director of Lacerta Therapeutics and Chair of the Scientific Advisory Board at Biostem Life Sciences. He has broad expertise across the viral vector product development continuum from discovery through GMP-compliant manufacturing to support IND-enabling preclinical and early stage clinical programs.
Dr. Avery Posey
Marie Berger
WHO WILL BE THERE
PAST ATTENDEES
2022 Agenda
The Onco Cell Therapy Summit Europe 2022 Agenda is launching this summer!
In the meantime, take a look at some of our industry-leading speakers from our past Summits...
Browse Top Industry Speakers
POSTER SUBMISSION
Are you looking to showcase your recent work to the Onco Cell Therapy Summit community?
Our dedicated poster session is the perfect way to get your research noticed. To present a poster, you need to register as a delegate. Please note that there is limited space available, and poster space is assigned on a first-come, first-served basis (subject to checks and successful registration). At the event, your presentation will be displayed in a dedicated poster area. The poster presentation session time of taking place is to be confirmed.
The poster abstract submission deadline is on 3rd June.
Abstracts received after this time may not be accepted, so please submit your abstract as soon as possible! Academics that submit a poster abstract before 3rd June get a 40% discount!
Posters should be sized A0 (841mm x 1189mm) in portrait orientation.
If you have any questions, please contact [email protected]
Click HERE to make a submission.
TESTIMONIALS
2021 Expertise Partners
Miltenyi Biotec
Website: www.miltenyibiotec.com
At Miltenyi Biotec, we are committed to enabling the delivery of new cell and gene therapy (CGT) treatment options to patients with unmet medical needs. We develop tailored cell processing protocols for our GMP-compliant cell processing platform, the CliniMACS Prodigy®, to enable fully closed and automated manufacturing of complex CGT products. In addition, we offer contract development and GMP manufacturing of CGT products as well as design, development, and production of tailored GMP lentiviral vectors
Genscript Probio
Website: https://www.genscriptprobio.com/
GenScript ProBio is the bio-pharmaceutical CDMO segment of the world's leading biotech company GenScript Biotech Corporation (Stock Code: 1548.HK). Founded in 2002 in New Jersey, GenScript started business from gene synthesis. Now, GenScipt ’s businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, as well as cell therapy.
In Jan 2019, GenScript established the Biologics Development Business Unit (BDBU) which is the predecessor of GenScript ProBio.
The name of "ProBio" indicates 3 core philosophies - being PROACTIVE, PROFESSIONAL and PROCESS-oriented. GenScript ProBio shows our dedication to proactively provide end to end service (discovery to commercialization) with professional solutions, and efficient process to accelerate drug development for customers.
GenScript ProBio has established the integrated innovative biologics CDMO platforms, covering two major service areas: therapeutic antibody drug and gene & cell therapy. We are committed to driving innovation and accelerating biologics development from target to market.
GenScript ProBio's one-stop antibody drug development solutions include antibody drug discovery (hybridoma, phage display, single B cell, fully human and bispecific antibody technologies), antibody engineering (antibody humanization, affinity maturation, developability assessment and optimization), antibody development (stable cell line generation, process development), and clinical and commercial manufacturing. GenScript ProBio's integrated GCT solution covers IND preparation as well as clinical sample and commercial production. Process development quality systems ensure compliance, data integrity and traceability, and all test deviations are strictly studied and documented. With the principle of "providing the best-in-class quality to and serving the interests of customers", GenScript ProBio is committed to helping customers to shorten the timeline for biological drugs from development to clinical use, significantly cutting down the R&D costs, accelerating the commercialization of medicines, and building a healthy future while making contributions to the development of the pharmaceutical industry.
2021 Tech Showcase Partner
Myriade
Website: http://www.myriadelab.com/en/
Myriade is a French company created in 2017 that develops an innovative nanoscale imaging technology: the VIDEODROP
Based on the principles of interferometry, the Videodrop makes it possible to visualize living nanoparticles in the range of 30 nm and 10 microns without labeling, in real time and in a single drop.
The Videodrop processing algorithms compute the concentration and size distribution of the nanoparticles and enable to analyze complex mixtures of phages (T4, lambda) for applications in phagotherapy, continuously monitor viral vector solutions (Lentiviruses, adenoviruses) for gene and cell therapy, and distinguish the different types of EVs to vectorize, diagnose or treat
2021 Event Partners
Anemocyte
Website: www.anemocyte.com
Anemocyte is a Biotech Manufacturing Organization (BMO); a biotech company active in the field of Cell and Gene Therapies (CGTs) that addresses CGT needs pro-actively offering one stop shop solutions and fostering exciting innovations.
Our business:
- Process development and GMP capabilities (Somatic Cells, Non-Viral Modified Cells, Vesicles)
- Plasmids for Viral Vector Manufacturing.
- Project Exellula: to address up to commercial scale needs for CGTs Including Viral Vectors modified cells.
- Big Data Analysis of CGTs
Our experience:
- More than 15 years of GMP manufacturing of CGTs and biological drugs;
- More than 60 years of Contract Manufacturing within our Group (Nine Trees Group)
Bio-Techne
Website: www.bio-techne.com
Bio-Techne offers a full range of products and services for Targeted Protein Degradation research and development, including: small molecule Protein Degraders (e.g. PROTAC® degraders); aTAG and dTAG Degraders plus custom TAG knock-in cell lines; Degrader Building Blocks, Ubiquitin-Proteasome System Proteins and Assays; Assays for Protein Degradation and Custom Degrader Services.
2021 Media Partners
Gene Therapy Net
Website: www.genetherapynet.com
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
World Pharma Today
Website: https://www.worldpharmatoday.com/
Please visit our website for more information.Pharma Journalist
Website: www.pharmajournalist.com
Pharma Journalist is a leading international B2B magazine providing the global information and the recent updates in the Pharmaceutical Industry.
Our editorial staff works dedicatedly to provide latest information of Pharmaceutical Industry in the form of articles, news, trends, analysis, market report, press releases, whitepapers, case studies, etc. which helps Industry professionals and decision makers to stay on the top of this fast-paced industry.
Various Online marketing services and promotional activities through Pharma Journalist helps companies and organizations to reach their target audience and create brand awareness.
CheckRare
Website: https://checkrare.com/
CheckRare is a learning platform for health care professionals and patients. Our platform allows users to gain insight and learn about rare diseases, current and emerging therapies, clinical trials, and the BioPharma companies behind them. Our peer-to-peer content is a trusted source for education and industry-related content. Our native content and sponsored programs are developed through our website, e-newsletter, social media platforms, and live meetings. We are a trusted, strategic partner with all major organizations in the global network of rare disease advisors and advocates. There is no fee to register on CheckRare and all content is free of charge.
Become a Partner
Kisaco Research provides the platform where industry executives can network, learn and meet potential industry partners.
Far from the typical ‘meet-and-greet’ experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand.
Your partnership with Kisaco Research will offer you a strategic approach that is an extension and enhancement of your own marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets.
Find out more by calling us at +44 (0)20 3696 2920 or email [email protected]
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.